rs5177 — LRP8 LRP8 3'UTR variant

The LRP8 Haplotype Variant — A 3'UTR Risk Tag for Premature Heart Disease

LRP8, also known as ApoER2 (apolipoprotein E receptor 2), is the only member of the low-density lipoprotein receptor family expressed in platelets. It plays a central role in platelet activation, lipoprotein metabolism¹¹ lipoprotein metabolism
LRP8 binds apolipoprotein E-containing lipoproteins and modulates their clearance from the bloodstream, and inflammatory signaling in macrophages and endothelial cells. The rs5177 variant sits in the 3' untranslated region of LRP8 and has been studied primarily as part of a haplotype block flanking the functional R952Q coding variant — together forming the TACGC haplotype²² TACGC haplotype
a five-SNP haplotype (rs7546246, rs2297660, rs3737983, R952Q/rs5174, rs5177) found exclusively in patients with familial and early-onset coronary artery disease and myocardial infarction.

The C allele at rs5177 marks one end of this risk haplotype in white populations and is notably absent from most African-ancestry populations (~1% frequency), while reaching moderate frequencies in Europeans (~32%) and high frequencies in East Asian populations (~46%), though the haplotype association with CAD has not been established in East Asian cohorts.

The Mechanism

rs5177 is a 3'UTR variant³³ 3'UTR variant
variants in the 3' untranslated region regulate mRNA stability, translation efficiency, and miRNA binding sites, altering how much protein is ultimately produced from the gene. Studies in psychiatric genetics examining LRP8 expression found that rs5177 is an expression quantitative trait locus (eQTL)⁴⁴ expression quantitative trait locus (eQTL)
the allele at this position predicts LRP8 mRNA levels in brain and other tissues, confirming it has a real functional effect on LRP8 expression rather than being a purely neutral tag.

The cardiovascular relevance of LRP8 expression changes arises from the protein's role in platelets — LRP8 is the only LRP family member expressed on platelets⁵⁵ LRP8 is the only LRP family member expressed on platelets
where it modulates HDL-mediated inhibition of platelet activation via apolipoprotein E signaling. Increased LRP8 expression has been associated with enhanced platelet reactivity and thrombotic risk. The R952Q coding variant (rs5174)⁶⁶ R952Q coding variant (rs5174)
a glutamine substitution at position 952 of the LRP8 cytoplasmic tail in tight haplotype linkage with rs5177 further increases p38 MAPK activation by oxidized LDL, amplifying the platelet and inflammatory response to atherogenic lipoproteins.

Additionally, LRP8-deficient mouse models⁷⁷ LRP8-deficient mouse models
animals lacking functional ApoER2 develop aortic dissection under angiotensin II infusion through dysregulated macrophage activity, suggesting LRP8 expression level in myeloid cells affects vascular wall integrity under hypertensive stress.

The Evidence

The strongest evidence comes from a series of studies by Shen, Wang, and colleagues using the GeneQuest family cohort of patients with premature coronary artery disease and MI. The 2007 discovery paper⁸⁸ 2007 discovery paper
Shen GQ et al., American Journal of Human Genetics 2007;81(4):780-91 identified the LRP8 locus through genome-wide linkage analysis of 428 families with premature MI, then fine-mapped to the R952Q variant. By 2014, haplotype analysis including rs5177⁹⁹ haplotype analysis including rs5177
Shen GQ et al., Circulation Cardiovascular Genetics 2014;7(4):514-20 showed the TACGC risk haplotype was present only in CAD/MI patients and absent from healthy controls, achieving genome-wide significance of P=7.4×10⁻⁷ for CAD and P=2.2×10⁻⁹ for MI¹⁰¹⁰ genome-wide significance of P=7.4×10⁻⁷ for CAD and P=2.2×10⁻⁹ for MI
in the GeneQuest cohort of 381 premature CAD cases vs. 560 controls, with replication in an Italian cohort of 248 familial MI patients (P=0.041). Notably, TACGC homozygotes showed earlier disease onset and higher LDL cholesterol levels¹¹¹¹ earlier disease onset and higher LDL cholesterol levels
compared to heterozygotes, indicating a dose-response relationship.

Complementary 2013 haplotype work¹²¹² 2013 haplotype work
Shen GQ et al., Gene 2013;521(1):78-81 identified a protective TCCGC haplotype (rs5177 G allele) with OR 0.53 for CAD (P=4.0×10⁻¹¹) and OR 0.42 for MI (P=6.5×10⁻¹²)¹³¹³ OR 0.53 for CAD (P=4.0×10⁻¹¹) and OR 0.42 for MI (P=6.5×10⁻¹²)
in the GeneQuest cohort, replicated in Italy with OR 0.71 (P=0.004), reinforcing that the G allele at rs5177 tags the protective haplotype.

Critically, a large null replication¹⁴¹⁴ large null replication
Lieb W et al., Journal of Molecular Medicine 2008;86(10):1163-70 examined LRP8 variants across four German and British cohorts totaling over 6,700 participants and found no significant association between LRP8 variants (including the rs5177 proxy rs5174) and familial or sporadic MI. This limits evidence confidence — the association appears strongest in selected familial early-onset cohorts and was absent in the South Korean replication population, suggesting population- or family-history-specific enrichment.

Practical Implications

The C allele at rs5177 tags the LRP8 risk haplotype in individuals of European ancestry with a family history of premature heart disease. The effect is most meaningful in the context of familial cardiovascular disease — where it may represent a heritable molecular marker — rather than as a general population risk predictor. The evidence supports heightened attention to platelet function, lipid management, and inflammatory markers in C allele carriers with relevant family history.

Monitoring LDL cholesterol levels is particularly important: the TACGC haplotype is associated with elevated plasma LDL and triglycerides¹⁵¹⁵ elevated plasma LDL and triglycerides
particularly in patients with early-onset CAD, suggesting lipid optimization should be a primary intervention target. Given LRP8's role in platelet activation, antiplatelet strategies may be especially relevant for affected individuals.

Interactions

The rs5177 C allele exists in tight haplotype linkage with the functional R952Q coding variant (rs5174)¹⁶¹⁶ R952Q coding variant (rs5174)
a missense change in the LRP8 cytoplasmic tail that increases p38 MAPK activation by oxidized LDL and enhances platelet reactivity. The combined TACGC haplotype (spanning rs7546246, rs2297660, rs3737983, rs5174, and rs5177) represents a coherent risk unit in white populations — the individual SNPs have limited power alone but together define a molecular diagnostic marker for familial premature CAD. When rs5177 C is present alongside rs5174 Q (risk) allele, the combined haplotype effect is stronger than either variant alone.